SIA
HAE icon

Sit Investment Associates’s Haemonetics HAE Stock Holding History

Sit Investment Associates’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Buy
+2,110
New +$136K ﹤0.01% 461
2014
Q1 		– Sell
-72,654
Closed -$3.06M – 461
2013
Q4 		$3.06M Sell
72,654
-2,300
-3% -$94.6K 0.05% 242
2013
Q3 		$2.99M Hold
74,954
– – 0.06% 233
2013
Q2 		$3.1M Buy
+74,954
New +$3.03M 0.06% 224

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sit Investment Associates's HAE Position: Q2 2026 in Review

Sit Investment Associates opened a new position in Haemonetics (HAE) in Q2 2026: 2,110 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #461 among its holdings. This is a return to the name: Sit Investment Associates previously reported a position in HAE as recently as Q4 2013.

Sit Investment Associates first reported a position in HAE in Q2 2013 and has held it in 4 quarters since. The position peaked at $3.1M in Q2 2013. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Sit Investment Associates held 2,110 shares of Haemonetics worth $158K as of Q2 2026.
  • Haemonetics was a new Sit Investment Associates position in Q2 2026.
  • Haemonetics made up ﹤0.01% of Sit Investment Associates's portfolio in Q2 2026, its #461 holding.
  • Sit Investment Associates first reported a position in Haemonetics in Q2 2013 and has held it in 4 quarters since.
  • Sit Investment Associates's Haemonetics position peaked at $3.1M in Q2 2013.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.